CrossAssetDataThe Company File
···
VSEE

VSee Health, Inc.

VSee Health, Inc. is classed by the SEC under Services-Health Services (industry code 8000), based in Boca Raton, FL. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $15 million and a loss of $15 million (its filed statements).

Usage business Services-Health Services Boca Raton, FL filings since 2021 7 of 9 filed, 2 estimated
Ask the desk about VSEE → Compare VSEE with ATPC → Price chart on TradingView ↗ Full EDGAR file ↗ Watch VSEE →

Sector peers: ATPCTALKDCGOEUDA

4.2/10headline grade
vs its business-model standard
3.5/10past 3.2/10present 6.2/10future

Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a usage business: prior from its industry code (SEC 8000, Services-Health Services); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.

The grade, in three tenses

Headline 4.2 out of ten, 7 of 9 metrics filed and 2 estimated: past 3.5 out of ten, present 3.2 out of ten, future 6.2 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.

The nine metrics

  • Surviving crises (past): 0.3 out of ten. 22 warning events since 2021; the latest 2026-08-04. 3rd percentile among 15 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Track record (past): 6.7 out of ten. +59.2% a year over 3 filed years; profitable in 0 of 3. 67th percentile among 14 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Shareholder treatment (past): 1.8 out of ten. CrossAssetData estimate 1.8/10, confidence 35 of 100 (one part). 18th percentile among 14 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
  • Financial health (present): 2.1 out of ten. ROE -270%: lost 270¢ per shareholder dollar. Leverage 76%: owes 76¢ per asset dollar. 21st percentile among 14 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Industry position (present): 4.2 out of ten. bottom 42% of 14 in its family; net margin -100.6%. 42nd percentile among 14 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Leadership (present): 2.8 out of ten. bottom 28% of 10 in its family for leadership; chief executive since 2024. 28th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
  • Room to expand (future): 4.7 out of ten. bottom 47% of 14 in its family for room to expand. 47th percentile among 14 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Growth drivers (future): 7.6 out of ten. top 24% of 14 in its family for growth drivers. 76th percentile among 14 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Expectations vs reality (future): 5.3 out of ten. CrossAssetData estimate 5.3/10, confidence 20 of 100 (family median). 50th percentile among 12 sector filers. A CrossAssetData estimate, not a filed reading: family median, confidence 20 of 100; its next annual report on file with the inputs replaces this estimate with the filed reading.

The filing record

Newest annual report: Form 10-K filed 2026-03-31 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-14 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2024-11-18 for the period ended 2024-11-15 (on EDGAR). Newest filing: Form S-1, 2026-10-01. Filings on record since 2021. Read from EDGAR 2026-10-12.

Where the revenue comes from

Product and service lines in fiscal 2025: Telehealth Fees 26%, Health Care Patient Service 23%, Subscription and Circulation 22%, Professional Services and Other Fees 21%, Technology Service 7%, Institutional Fees under 1%. As tagged in its annual report (Form 10-K, filed 2026-03-31).

Who runs it

Chen, Milton (Co-Chief Executive Officer); Aisiku, Imoigele (Co-Chief Executive Officer); Leonard, Jerry (Chief Financial Officer); Metzger, Scott (director); O'Sullivan, Colin P. (director); Fairfax, Cydonii V. (director); Lowdermilk, Kevin (director); Wickersham, David L. (director). 8 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.

This file: Overview · Past · Present · Future · Filings · every company on file

Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.